Canada Life’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,330
| Closed | -$44K | – | 2296 |
|
|
2023
Q1 | $44K | Buy |
25,330
+13,797
| +120% | +$39.4K | ﹤0.01% | 2087 |
|
|
2022
Q4 | $37K | Sell |
11,533
-28,949
| -72% | -$112K | ﹤0.01% | 2139 |
|
|
2022
Q3 | $198K | Buy |
40,482
+30,713
| +314% | +$158K | ﹤0.01% | 1870 |
|
|
2022
Q2 | $40K | Buy |
9,769
+698
| +8% | +$3.02K | ﹤0.01% | 2099 |
|
|
2022
Q1 | $55K | Buy |
9,071
+636
| +8% | +$3.78K | ﹤0.01% | 2135 |
|
|
2021
Q4 | $63K | Buy |
8,435
+618
| +8% | +$5.37K | ﹤0.01% | 2115 |
|
|
2021
Q3 | $71K | Hold |
7,817
| – | – | ﹤0.01% | 2136 |
|
|
2021
Q2 | $93K | Hold |
7,817
| – | – | ﹤0.01% | 2104 |
|
|
2021
Q1 | $97K | Hold |
7,817
| – | – | ﹤0.01% | 2108 |
|
|
2020
Q4 | $122K | Hold |
7,817
| – | – | ﹤0.01% | 2075 |
|
|
2020
Q3 | $74K | Hold |
7,817
| – | – | ﹤0.01% | 2099 |
|
|
2020
Q2 | $70K | Hold |
7,817
| – | – | ﹤0.01% | 2140 |
|
|
2020
Q1 | $50K | Hold |
7,817
| – | – | ﹤0.01% | 2133 |
|
|
2019
Q4 | $65K | Buy |
+7,817
| New | +$71.9K | ﹤0.01% | 2178 |
|
|
2019
Q3 | – | Sell |
-10,811
| Closed | -$116K | – | 2079 |
|
|
2019
Q2 | $116K | Sell |
10,811
-1,956
| -15% | -$20.8K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $121K | Hold |
12,767
| – | – | ﹤0.01% | 2011 |
|
|
2018
Q4 | $141K | Hold |
12,767
| – | – | ﹤0.01% | 2029 |
|
|
2018
Q3 | $216K | Hold |
12,767
| – | – | ﹤0.01% | 1959 |
|
|
2018
Q2 | $181K | Hold |
12,767
| – | – | ﹤0.01% | 1999 |
|
|
2018
Q1 | $242K | Hold |
12,767
| – | – | ﹤0.01% | 1907 |
|
|
2017
Q4 | $209K | Hold |
12,767
| – | – | ﹤0.01% | 1954 |
|
|
2017
Q3 | $182K | Buy |
12,767
+7,667
| +150% | +$84.8K | ﹤0.01% | 1978 |
|
|
2017
Q2 | $45K | Hold |
5,100
| – | – | ﹤0.01% | 2354 |
|
|
2017
Q1 | $26K | Hold |
5,100
| – | – | ﹤0.01% | 2432 |
|
|
2016
Q4 | $15K | Hold |
5,100
| – | – | ﹤0.01% | 2512 |
|
|
2016
Q3 | $24K | Hold |
5,100
| – | – | ﹤0.01% | 2458 |
|
|
2016
Q2 | $29K | Hold |
5,100
| – | – | ﹤0.01% | 2428 |
|
|
2016
Q1 | $31K | Hold |
5,100
| – | – | ﹤0.01% | 2275 |
|
|
2015
Q4 | $47K | Hold |
5,100
| – | – | ﹤0.01% | 2172 |
|
|
2015
Q3 | $29K | Hold |
5,100
| – | – | ﹤0.01% | 2260 |
|
|
2015
Q2 | $56K | Hold |
5,100
| – | – | ﹤0.01% | 2156 |
|
|
2015
Q1 | $80K | Hold |
5,100
| – | – | ﹤0.01% | 1926 |
|
|
2014
Q4 | $77K | Hold |
5,100
| – | – | ﹤0.01% | 1910 |
|
|
2014
Q3 | $55K | Hold |
5,100
| – | – | ﹤0.01% | 1999 |
|
|
2014
Q2 | $78K | Hold |
5,100
| – | – | ﹤0.01% | 1730 |
|
|
2014
Q1 | $92K | Hold |
5,100
| – | – | ﹤0.01% | 1473 |
|
|
2013
Q4 | $71K | Buy |
+5,100
| New | +$58.7K | ﹤0.01% | 1581 |
|
Other funds holding SGMO
WA
RCMU
CS
Canada Life's SGMO Position: Q2 2023 in Review
Canada Life sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2023, closing a stake of 25,330 shares — an estimated $44K sold.
Canada Life first reported a position in SGMO in Q4 2013 and held it in 37 quarters. The position peaked at $242K in Q1 2018. 152 funds tracked by Wall St. Rank hold SGMO as of Q2 2023.
- Canada Life reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2023 after selling out during the quarter.
- Canada Life sold 25,330 SANGAMO THERAPEUTICS INC shares in Q2 2023, an estimated $44K.
- Canada Life first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 37 quarters.
- Canada Life's SANGAMO THERAPEUTICS INC position peaked at $242K in Q1 2018.
- 152 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2023.
Based on Canada Life's 13F filing for Q2 2023, filed 10 Aug 2023.